Results 191 to 200 of about 770,723 (305)

Outcome and Toxicity Profile of Stereotactic Body Radiation Therapy for Adrenal Tumours in Dogs

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 150-159, March 2026.
ABSTRACT Stereotactic body radiation therapy (SBRT) has become a non‐invasive alternative option for canine adrenal tumours with high surgical risks; however, its clinical benefits and risks are still to be fully understood. The goal of this multi‐institutional retrospective study was to describe the clinical outcome and safety of SBRT for the ...
Lily Thorsen   +9 more
wiley   +1 more source

Fluorine‐18 Fluorodeoxyglucose‐Positron Emission Tomography/Computed Tomography for Detection of Lymph Node Metastasis in Canine Mast Cell Tumour

open access: yesVeterinary and Comparative Oncology, Volume 24, Issue 1, Page 197-207, March 2026.
ABSTRACT Lymph node (LN) metastasis has been associated with shorter survival times in dogs with mast cell tumour (MCT), and treatment of metastatic LN with lymphadenectomy or irradiation has been demonstrated to improve outcomes. Identification of metastatic LN in dogs with MCT is therefore of both prognostic and therapeutic significance.
Alison C. Williams   +5 more
wiley   +1 more source

Case Report: Solitary adrenal metastasis from esophageal adenocarcinoma. [PDF]

open access: yesFront Med (Lausanne)
Machchhar R   +6 more
europepmc   +1 more source

Palliative Radiotherapy Provided Good Pain Relief for Painful Adrenal Metastasis. [PDF]

open access: yesCase Rep Oncol, 2021
Endo M   +10 more
europepmc   +1 more source

Hepatic resections for metastatic tumors [PDF]

open access: yes, 1989
Iwatsuki, S, Starzl, TE
core  

ADRENAL METASTASIS IN RENAL CELL CARCINOMA

open access: yesThe Japanese Journal of Urology, 1988
T, Kurozumi, H, Yagi, T, Omoto, Y, Iwata
openaire   +2 more sources

Evolving strategies in prostate cancer: Emerging approaches and unmet needs from the Bridging the Gaps in Prostate Cancer expert panel

open access: yesCancer, Volume 132, Issue 4, 15 February 2026.
Abstract Background The expansion of treatment options for prostate cancer (PC) has improved disease‐specific and overall survival outcomes but has also raised questions about the optimal level of treatment needed for patients based on their individual prognosis and accounting for potential toxicity, incorporating quality of life considerations ...
Rana R. McKay   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy